NOVOCURE LTD's ticker is and the CUSIP is G6674U958. A total of 6 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,663 | -95.6% | 77,200 | +4441.2% | 0.00% | – |
| Q3 2022 | $129,000 | +43.3% | 1,700 | +30.8% | 0.00% | – |
| Q2 2022 | $90,000 | -98.6% | 1,300 | -98.3% | 0.00% | -100.0% |
| Q1 2022 | $6,338,000 | +5363.8% | 76,500 | +7550.0% | 0.00% | – |
| Q3 2021 | $116,000 | -98.9% | 1,000 | -98.3% | 0.00% | -100.0% |
| Q4 2020 | $10,382,000 | +670.7% | 60,000 | +200.0% | 0.00% | – |
| Q1 2020 | $1,347,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 63,500 | $3,818,890 | 0.01% |
| SIMPLEX TRADING, LLC | 87,600 | $5,268 | 0.01% |
| JANE STREET GROUP, LLC | 161,900 | $9,736,666 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |